Protocolized Initiation of Clonidine to Prevent Dexmedetomidine Withdrawal

• Status: Not yet recruiting
• Trial end date: 2023-10-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if the protocolized use of clonidine will reduce dexmedetomidine withdrawal symptoms, reduce PICU length of stay, and reduce costs related to sedation during hospital admission.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The University of Texas Health Science Center, Houston
• Treatments: Clonidine

Criteria

Inclusion Criteria:

• Dexmedetomidine infusion for greater than or equal to 72 hours

Exclusion Criteria:

• Admission for head trauma

• Psychiatric history

• Use of alpha-2 agonist medications at home

• Death while on dexmedetomidine